background : magnetic resonance imaging of the breast is becoming a useful adjunct to mammography and sonography for the detection of breast lesions. however, it is not yet accepted as a routine examination for all breast cancer patients due to the lack of data regarding whether breast magnetic resonance imaging impacts recurrence or survival. this trial examines the use of magnetic resonance i...

introduction: breast cancer is one of the provalent cancers in the world. this cancer as well as other solid tumors, in the course of its development has phases in this order: epithelial dysplasia, carcinoma insitu, invassiveness and metastasis. breast cancer diagnosis is generally made with pathology methods. in this survey, measuring angiostatin (which is one of the most important and potent...

Breast cancer has become a widespread disease around the world in young women. Expert systems, developed by data mining techniques, are valuable tools in diagnosis of breast cancer and can help physicians for decision making process. This paper presents a new hybrid data mining approach to classify two groups of breast cancer patients (malignant and benign). The proposed approach, AP-AMBFA, con...

Although breast tuberculosis still remains rare, but in endemic countries should be in differential diagnosis of breast cancer and abscess. Imaging modalities cannot distinguish between cancer and tuberculosis. Acid fast bacilli stain; culture and PCR are helpful diagnostic methods but unfortunately are not very sensitive. Negative results do not rule out this diagnosis, so it seems definite di...

Triple negative breast cancer (TNBC): challenges and solutions via the immune cells TNBC is one of the most complicated types of breast cancer to treat. It is generally diagnosed based on the absence of three receptors: estrogen, progesterone, and human epidermal growth factor receptor 2 (HER2) and is thus defined as a triple negative. TNBC is often more aggressive with lower survival rates...

Breast cancer is the most prevalent malignancy and the second in mortality rate cancers among all cancers in women globally. In Iran it adds up to 16 percent of all cancers and is the most prevalent cancer in Iranian women. PALB2, identified as a partner and localizer of BRCA2 and proposed to have some roles in DNA damage response, has recently been identified as a breast canc...

Will the detected lung foci in patients with a burdened oncological history (breast cancer) always be metastatic? In response to question posed, we present clinical case of pulmonary sarcoidosis mimicking metastatic lesion metaplastic breast cancer. And remind need for differential diagnosis, despite patient and radiation diagnostics data.